Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
149.01
Oct 23 • 3:59 PM ET Dollar change+0.89 Percentage change(0.60%)
Aftermarket Close
147.74
Aftermarket • 7:40 PM ET Dollar change-1.27 Percentage change(-0.85%)
Index
S&P 500
Market Cap
10.33B
Enterprise Value
10.75B
Income
375.30M
Sales
3.05B
Book/sh
20.51
Cash/sh
7.71
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
5400
IPO
May 15, 2007
P/E
29.54
Forward P/E
19.29
PEG
0.83
P/S
3.38
P/B
7.27
P/C
19.32
P/FCF
35.18
EV/EBITDA
16.80
EV/Sales
3.52
Quick Ratio
1.80
Current Ratio
2.45
Debt/Eq
0.67
LT Debt/Eq
0.65
Option/Short
Yes / Yes
EPS (ttm)
5.04
EPS next Y
7.72
EPS next Q
1.59
EPS this Y
30.93%
EPS next Y
18.68%
EPS next 5Y
23.30%
EPS past 3/5Y
275.33% 102.14%
Sales past 3/5Y
27.54% 24.53%
EPS Y/Y TTM
59.39%
Sales Y/Y TTM
29.41%
EPS Q/Q
234.76%
Sales Q/Q
23.51%
Insider Own
0.44%
Insider Trans
2.32%
Inst Own
106.10%
Inst Trans
1.35%
ROA
11.31%
ROE
26.02%
ROIC
15.96%
Gross Margin
72.16%
Oper. Margin
16.88%
Profit Margin
12.29%
SMA20
8.42%
SMA50
6.06%
SMA200
-18.20%
Trades
Shs Outstand
69.35M
Shs Float
69.05M
52W High
354.88 -58.01%
52W Low
126.40 17.89%
Volatility
3.17% 2.94%
ATR (14)
4.58
RSI (14)
65.96
Beta
1.08
Rel Volume
0.47
Avg Volume
1.69M
Volume
803,296
Perf Week
5.61%
Perf Month
9.74%
Perf Quarter
-9.69%
Perf Half Y
-21.39%
Perf YTD
-47.58%
Perf Year
-53.93%
Perf 3Y
1.37%
Perf 5Y
-51.04%
Perf 10Y
271.78%
Prev Close
148.12
Price
149.01
Change %
0.60%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McEvoy AshleyPresident and CEOAug 21 '26Buy147.471,100162,21723,731Aug 24 07:08 AM
STONESIFER TIMOTHY C.DirectorJun 03 '26Buy143.512,790400,3939,041Jun 04 04:25 PM
BORIO LUCIANADirectorJun 03 '26Sale143.2741859,8874,329Jun 04 04:23 PM
WEATHERMAN ELIZABETH HDirectorJun 03 '26Buy144.203,450497,49010,352Jun 03 04:19 PM
BORIO LUCIANADirectorJun 03 '26Proposed Sale143.2641859,885Jun 03 03:07 PM
MINOGUE MICHAEL RDirectorFeb 25 '26Buy246.232,030499,84717,483Feb 26 07:05 AM
McEvoy AshleyPresident and CEOFeb 20 '26Buy239.354,3001,029,20513,916Feb 23 08:14 AM
Frederick Wayne A.I.DirectorDec 15 '25Sale293.091,851542,5102,158Dec 16 04:04 PM
Frederick Wayne A.I.DirectorDec 15 '25Proposed Sale293.091,851542,500Dec 15 03:03 PM
STONESIFER TIMOTHY C.DirectorDec 05 '25Buy311.73962299,8844,591Dec 08 04:02 PM
Manea DanFormer OfficerNov 26 '25Proposed Sale326.644,4751,461,716Nov 26 04:31 PM
Manea DanFormer OfficerNov 24 '25Proposed Sale340.952,306786,228Nov 24 04:06 PM
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
CEOMs. Ashley A. McEvoy
Executive VP & CFOMs. Flavia H. Pease
Executive VP & COOMr. Eric Benjamin
Senior VP & General CounselMr. John Wodick Kapples J.D.
Senior Vice President of Global OperationsMr. Prem Singh